Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
09/2012
09/20/2012US20120240247 Jnk3 modulators and methods of use
09/20/2012US20120238634 Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators
09/20/2012US20120238628 Dihydronaphthalene and naphthalene derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators
09/20/2012US20120238620 TRYPTOPHANYL-tRNA SYNTHETASE-DERIVED POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
09/20/2012US20120238619 Micro-rna for the regulation of cardiac apoptosis and contractile function
09/20/2012US20120238615 Alpha adrenergic receptor modulators
09/20/2012US20120238613 Sec-hydroxycyclohexyl derivatives
09/20/2012US20120238611 Dual-acting benzoimidazole antihypertensive agents
09/20/2012US20120238608 Angiotensin ii receptor antagonists
09/20/2012US20120238607 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
09/20/2012US20120238606 Azilsartan organic amine salts, preparation method and use thereof
09/20/2012US20120238605 Otamixaban for treatment of elderly and renal impaired non-st elevation myocardial infarction patients
09/20/2012US20120238598 Derivatives of 7 alkynyl-1,8 naphthyridones, preparation method thereof and use of same in therapeutics
09/20/2012US20120238594 Azaspirodecanone compounds
09/20/2012US20120238593 Heterocyclic compounds and uses thereof
09/20/2012US20120238588 1H-Pyrrolo[2,3-B]Pyridines
09/20/2012US20120238587 Novel pyridopyrimidine derivatives and use thereof
09/20/2012US20120238586 Fatty acid acetylated salicylates and their uses
09/20/2012US20120238582 Quinazoline derivatives
09/20/2012US20120238578 Compositions useful as inhibitors of voltage-gated sodium channels
09/20/2012US20120238577 Prostaglandin transporter inhibitors and uses thereof
09/20/2012US20120238576 Triazine Derivatives and their Therapeutical Applications
09/20/2012US20120238574 (1, 1, 1,3,3,3 -hexafluoro-2 hydroxypropan- 2 -yl) phenyl derivative, pharmaceutical compositions thereof and their use for the treatment of atherosclerosis
09/20/2012US20120238571 Indazole derivatives as pi 3-kinase
09/20/2012US20120238567 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands
09/20/2012US20120238565 Triazolopyridine compounds and their use as ask inhibitors
09/20/2012US20120238561 Morpholinothiazoles as alpha 7 positive allosteric modulators
09/20/2012US20120238559 Novel compounds
09/20/2012US20120238553 Novel benzodioxolyl-oxadiazolyl-diazabicyclononane derivatives and their medical use
09/20/2012US20120238551 Substituted Phenoxypropylcycloamine Derivatives as Histamine-3 (H3) Receptor Ligands
09/20/2012US20120238549 Nuclear Hormone Receptor Modulators
09/20/2012US20120238548 1,4-oxazepines as bace1 and/or bace2 inhibitors
09/20/2012US20120238547 2, 3, 6 - triamino substituted pyridines as kv7 (kcnq) channel modulators
09/20/2012US20120238544 Thieno- and furo-pyrimidine modulators of the histamine h4 receptor
09/20/2012US20120238530 Fatty acid acetylated salicylates and their uses
09/20/2012US20120238526 Aconitine compounds, compositions, uses, and preparation thereof
09/20/2012US20120238520 Novel Medical Use
09/20/2012US20120238510 Crystalline form of benzylbenzene sglt2 inhibitor
09/20/2012US20120238509 Urocortin 2 analogs and uses thereof
09/20/2012US20120238499 Methods of modulating apoptosis by administration of relaxin agonists or antagonists
09/20/2012US20120238490 Methods and compositions for the treatment of metabolic disorders
09/20/2012US20120237617 Use of nitrite salts in treating tissue damage
09/20/2012US20120237602 Press-coated orally-disintegrating tablets
09/20/2012US20120237590 Curcumin combination with anti-type 2 diabetic drugs for prevention and treatment of disease sequelae, drug-related adverse reactions, and improved glycemic control
09/20/2012US20120237588 Methods of improving cardiac function and attenuating and/or preventing cardiac remodeling with hsp20
09/20/2012US20120237565 Pegylated polyplexes containing two or more different polymers for polynucleotide delivery
09/20/2012US20120237560 Cardiac Compositions
09/20/2012US20120237528 Human Tissue Factor Antibody and Uses Thereof
09/20/2012US20120237514 Vascular endothelial cell growth factor antagonists and uses thereof
09/20/2012US20120237504 Compositions and methods for treating inflammation and fibrosis
09/20/2012US20120237482 Methods for treatment of neurological disorders by modulation of microglial activation
09/20/2012US20120237477 Methods and compositions for treating post-myocardial infarction damage
09/20/2012US20120237475 Novel Inhibitors
09/20/2012US20120237474 Fluorinated diaryl urea derivatives
09/20/2012US20120237442 Design and Construction of Novel Multivalent Antibodies
09/20/2012US20120234721 Diuretic and diuretic-like compound analogs
09/20/2012DE102011015142A1 Agens zur Prophylaxe und Behandlung altersassoziierter Krankheiten und Störungen sowie zur Verlängerung der Lebensdauer Agent for the prophylaxis and treatment of age-related diseases and disorders, as well as extending the life
09/20/2012CA2833562A1 Herbal polypharmaceutical for preventing and treating atherosclerosis
09/20/2012CA2830157A1 Guanidine compound
09/20/2012CA2830126A1 Sec-hydroxycyclohexyl derivatives as hsl inhibitors for the treatment diabetes
09/20/2012CA2830043A1 Novel phenylpyridine derivative and drug containing same
09/20/2012CA2829767A1 Npp1 fusion proteins
09/20/2012CA2829693A1 Pegylated apelin and uses thereof
09/20/2012CA2828378A1 Nitrogen-containing saturated heterocyclic compound
09/20/2012CA2827629A1 Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative, and use of these
09/19/2012EP2500345A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative
09/19/2012EP2500339A1 Crystalline forms of pitavastatin calcium
09/19/2012EP2500062A2 C-19 steroids for specific therapeutic uses
09/19/2012EP2500031A2 Compositions and Methods for Treating Vascular Permeability
09/19/2012EP2500024A1 Treatment of pulmonary hypertension with carbonic anhydrase inhibitors in combination with a sympathomimetic amine
09/19/2012EP2500018A1 Preventing and/or Treating Cardiovascular Disease and/or Associated Heart Failure
09/19/2012EP2499144A1 Quinoline and quinoxaline derivatives as kinase inhibitors
09/19/2012EP2499129A1 Quinoline and quinoxaline derivatives as kinase inhibitors
09/19/2012EP2499126A1 Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors
09/19/2012EP2499120A1 Novel 1,3-oxazolidine compounds and their use as renin inhibitors
09/19/2012EP2498797A2 Treatment of heart disease
09/19/2012EP2498796A2 Treatment of heart disease
09/19/2012EP2498779A1 Pemirolast for the treatment of systemic low grade inflammation
09/19/2012CN202437982U External-use medicine package for hemorrhoids preventive treatment
09/19/2012CN202437741U Chinese medicine patch for treating apoplexy
09/19/2012CN102686590A Pyrazoline dione derivatives as NADPH oxidase inhibitors
09/19/2012CN102686588A Novel solvates of methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate
09/19/2012CN102686571A Tricyclic heterocyclic compounds
09/19/2012CN102686279A 载体组合物 Carrier composition
09/19/2012CN102676621A Antihypertensive rapeseed peptide and preparation method and application of antihypertensive rapeseed peptide
09/19/2012CN102676349A Giant salamander bone healthcare wine and preparation method thereof
09/19/2012CN102675621A Poloxamer-niacin prodrug and preparation method thereof
09/19/2012CN102675449A Deletion form human keratinocyte growth factor-I disulfide bond mutation form and use thereof
09/19/2012CN102675417A Monocyte migration inhibition factor analogue, synthesis thereof and application thereof
09/19/2012CN102675380A Crystalline form of 1- (beta-D-glucopyranosyl) -4 -methyl- 3- [5- (4 -fluorophenyl) -2-thienylmethyl] benzene hemihydrate
09/19/2012CN102675338A Micronization prasugrel and medicinal composition of prasugrel
09/19/2012CN102675316A Quinazoline purine derivative and application thereof in preparation of diabetes drugs
09/19/2012CN102675299A Crystalline form of 1- (beta-D-glucopyranosyl) -4 -methyl- 3- [5- (4 -fluorophenyl) -2-thienylmethyl] benzene hemihydrate
09/19/2012CN102675290A Bicyclic dihydropyrazole compounds
09/19/2012CN102675289A Novel N-phenyl benzamide derivative serving as protein kinase inhibitor
09/19/2012CN102675286A Indazoles compound, and preparation method and application thereof, and medical composition
09/19/2012CN102675282A Substitutive quinoline compound and application method and uses thereof
09/19/2012CN102675228A Medicine for treating ischemic brain injury stroke and sequela of ischemic brain injury stroke and preparation method for medicine
09/19/2012CN102675114A Curcumin-containing acetylsalicylate derivative, preparation method and application thereof
09/19/2012CN102675104A Derivative of high veratryl alcohol and medical application of derivative of high veratryl alcohol
1 ... 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 ... 1595